Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases

被引:220
作者
Gan, Li [1 ]
Johnson, Jeffrey A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA
[2] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA
[3] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53705 USA
[4] Univ Wisconsin, Ctr Neurosci, Madison, WI 53705 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2014年 / 1842卷 / 08期
关键词
Oxidative stress; Nrf2-ARE pathway; Misfolded proteins; Neurodegenerative diseases; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSCRIPTION FACTOR NRF2; NAD(P)H-QUINONE OXIDOREDUCTASE ACTIVITY; ALPHA-SYNUCLEIN ACCUMULATION; DNA-BINDING PROTEIN-43; HUMAN SUBSTANTIA-NIGRA; COMPLEX I DEFICIENCY; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION;
D O I
10.1016/j.bbadis.2013.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative damage contributes to pathogenesis in many neurodegenerative diseases. As the indicator and regulator of oxidative stress, the Nrf2-ARE pathway has been shown dynamic changes and examined for its neuroprotective role in many cases. In this review, we summarize the progress of the Nrf2-ARE pathway in combating toxicity induced from typical misfolded protein aggregates in neurodegenerative diseases, and specifically the effects on the clearance of protein aggregates. This article is part of a Special Issue entitled: Misfolded Proteins, Mitochondrial Dysfunction, and Neurodegenerative Diseases. (C) 2013 Published by Elsevier B.V.
引用
收藏
页码:1208 / 1218
页数:11
相关论文
共 167 条
  • [1] The mammalian cap and collar family of transcription factors
    Alam, J
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (1-2) : 39 - 42
  • [2] Alam ZI, 1997, J NEUROCHEM, V69, P1326
  • [3] Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
    Alam, ZI
    Jenner, A
    Daniel, SE
    Lees, AJ
    Cairns, N
    Marsden, CD
    Jenner, P
    Halliwell, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1196 - 1203
  • [4] Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism
    Alba Sorolla, Ma
    Jose Rodriguez-Colman, Ma
    Tamarit, Jordi
    Ortega, Zaira
    Lucas, Jose J.
    Ferrer, Isidre
    Ros, Joaquim
    Cabiscol, Elisa
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (04) : 612 - 621
  • [5] Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
    Ando, Y
    Brännström, T
    Uchida, K
    Nyhlin, N
    Näsman, B
    Suhr, O
    Yamashita, T
    Olsson, T
    El Salhy, M
    Uchino, M
    Ando, M
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 156 (02) : 172 - 176
  • [6] Lipid Peroxidation Product 4-Hydroxy-2-Nonenal Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of α-Synuclein
    Bae, Eun-Jin
    Ho, Dong-Hwan
    Park, Eunbi
    Jung, Jin Woo
    Cho, Kyungcho
    Hong, Ji Hye
    Lee, He-Jin
    Kim, Kwang Pyo
    Lee, Seung-Jae
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (07) : 770 - 783
  • [7] Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease
    Barone, Maria Cecilia
    Sykiotis, Gerasimos P.
    Bohmann, Dirk
    [J]. DISEASE MODELS & MECHANISMS, 2011, 4 (05) : 701 - 707
  • [8] Proteome analysis of human substantia nigra in Parkinson's disease
    Basso, M
    Giraudo, S
    Corpillo, D
    Bergamasco, B
    Lopiano, L
    Fasano, M
    [J]. PROTEOMICS, 2004, 4 (12) : 3943 - 3952
  • [9] High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
    Bender, A
    Krishnan, KJ
    Morris, CM
    Taylor, GA
    Reeve, AK
    Perry, RH
    Jaros, E
    Hersheson, JS
    Betts, J
    Klopstock, T
    Taylor, RW
    Turnbull, DM
    [J]. NATURE GENETICS, 2006, 38 (05) : 515 - 517
  • [10] Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein α-Synuclein
    Beraud, Dawn
    Hathaway, Hannah A.
    Trecki, Jordan
    Chasovskikh, Sergey
    Johnson, Delinda A.
    Johnson, Jeffrey A.
    Federoff, Howard J.
    Shimoji, Mika
    Mhyre, Timothy R.
    Maguire-Zeiss, Kathleen A.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (01) : 94 - 117